nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefpodoxime—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00239	0.00239	CcSEcCtD
Cefpodoxime—Back pain—Vincristine—colon cancer	0.00237	0.00237	CcSEcCtD
Cefpodoxime—Flatulence—Irinotecan—colon cancer	0.00235	0.00235	CcSEcCtD
Cefpodoxime—Gastritis—Capecitabine—colon cancer	0.00235	0.00235	CcSEcCtD
Cefpodoxime—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00234	0.00234	CcSEcCtD
Cefpodoxime—Alopecia—Fluorouracil—colon cancer	0.00232	0.00232	CcSEcCtD
Cefpodoxime—Back pain—Irinotecan—colon cancer	0.00231	0.00231	CcSEcCtD
Cefpodoxime—Abdominal distension—Capecitabine—colon cancer	0.00231	0.00231	CcSEcCtD
Cefpodoxime—Asthma—Capecitabine—colon cancer	0.00229	0.00229	CcSEcCtD
Cefpodoxime—Anaemia—Vincristine—colon cancer	0.00227	0.00227	CcSEcCtD
Cefpodoxime—Agitation—Vincristine—colon cancer	0.00225	0.00225	CcSEcCtD
Cefpodoxime—Sweating increased—Capecitabine—colon cancer	0.00223	0.00223	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Irinotecan—colon cancer	0.00222	0.00222	CcSEcCtD
Cefpodoxime—Anaemia—Irinotecan—colon cancer	0.00221	0.00221	CcSEcCtD
Cefpodoxime—Bronchitis—Capecitabine—colon cancer	0.00221	0.00221	CcSEcCtD
Cefpodoxime—Vertigo—Vincristine—colon cancer	0.0022	0.0022	CcSEcCtD
Cefpodoxime—Leukopenia—Vincristine—colon cancer	0.0022	0.0022	CcSEcCtD
Cefpodoxime—Pancytopenia—Capecitabine—colon cancer	0.00218	0.00218	CcSEcCtD
Cefpodoxime—Malaise—Irinotecan—colon cancer	0.00215	0.00215	CcSEcCtD
Cefpodoxime—Vertigo—Irinotecan—colon cancer	0.00215	0.00215	CcSEcCtD
Cefpodoxime—Dysuria—Capecitabine—colon cancer	0.00215	0.00215	CcSEcCtD
Cefpodoxime—Neutropenia—Capecitabine—colon cancer	0.00215	0.00215	CcSEcCtD
Cefpodoxime—Syncope—Irinotecan—colon cancer	0.00214	0.00214	CcSEcCtD
Cefpodoxime—Leukopenia—Irinotecan—colon cancer	0.00214	0.00214	CcSEcCtD
Cefpodoxime—Convulsion—Vincristine—colon cancer	0.00212	0.00212	CcSEcCtD
Cefpodoxime—Hypertension—Vincristine—colon cancer	0.00212	0.00212	CcSEcCtD
Cefpodoxime—Anaemia—Fluorouracil—colon cancer	0.00211	0.00211	CcSEcCtD
Cefpodoxime—Loss of consciousness—Irinotecan—colon cancer	0.0021	0.0021	CcSEcCtD
Cefpodoxime—Dermatitis exfoliative—Methotrexate—colon cancer	0.00209	0.00209	CcSEcCtD
Cefpodoxime—Photosensitivity reaction—Capecitabine—colon cancer	0.00209	0.00209	CcSEcCtD
Cefpodoxime—Myalgia—Vincristine—colon cancer	0.00209	0.00209	CcSEcCtD
Cefpodoxime—Weight increased—Capecitabine—colon cancer	0.00209	0.00209	CcSEcCtD
Cefpodoxime—Cough—Irinotecan—colon cancer	0.00208	0.00208	CcSEcCtD
Cefpodoxime—Hyperglycaemia—Capecitabine—colon cancer	0.00207	0.00207	CcSEcCtD
Cefpodoxime—Hypertension—Irinotecan—colon cancer	0.00206	0.00206	CcSEcCtD
Cefpodoxime—Pneumonia—Capecitabine—colon cancer	0.00206	0.00206	CcSEcCtD
Cefpodoxime—Leukopenia—Fluorouracil—colon cancer	0.00205	0.00205	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00203	0.00203	CcSEcCtD
Cefpodoxime—Renal failure—Capecitabine—colon cancer	0.00201	0.00201	CcSEcCtD
Cefpodoxime—Discomfort—Irinotecan—colon cancer	0.00201	0.00201	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Vincristine—colon cancer	0.002	0.002	CcSEcCtD
Cefpodoxime—Stomatitis—Capecitabine—colon cancer	0.00199	0.00199	CcSEcCtD
Cefpodoxime—Convulsion—Fluorouracil—colon cancer	0.00198	0.00198	CcSEcCtD
Cefpodoxime—Confusional state—Irinotecan—colon cancer	0.00197	0.00197	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Vincristine—colon cancer	0.00196	0.00196	CcSEcCtD
Cefpodoxime—Haematuria—Capecitabine—colon cancer	0.00195	0.00195	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Irinotecan—colon cancer	0.00195	0.00195	CcSEcCtD
Cefpodoxime—Chest pain—Fluorouracil—colon cancer	0.00195	0.00195	CcSEcCtD
Cefpodoxime—Myalgia—Fluorouracil—colon cancer	0.00195	0.00195	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Vincristine—colon cancer	0.00193	0.00193	CcSEcCtD
Cefpodoxime—Epistaxis—Capecitabine—colon cancer	0.00193	0.00193	CcSEcCtD
Cefpodoxime—Discomfort—Fluorouracil—colon cancer	0.00192	0.00192	CcSEcCtD
Cefpodoxime—Shock—Irinotecan—colon cancer	0.00192	0.00192	CcSEcCtD
Cefpodoxime—Agranulocytosis—Capecitabine—colon cancer	0.00191	0.00191	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Irinotecan—colon cancer	0.00191	0.00191	CcSEcCtD
Cefpodoxime—Anorexia—Vincristine—colon cancer	0.00191	0.00191	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Irinotecan—colon cancer	0.00188	0.00188	CcSEcCtD
Cefpodoxime—Confusional state—Fluorouracil—colon cancer	0.00188	0.00188	CcSEcCtD
Cefpodoxime—Hypotension—Vincristine—colon cancer	0.00187	0.00187	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Fluorouracil—colon cancer	0.00187	0.00187	CcSEcCtD
Cefpodoxime—Anorexia—Irinotecan—colon cancer	0.00186	0.00186	CcSEcCtD
Cefpodoxime—Haemoglobin—Capecitabine—colon cancer	0.00185	0.00185	CcSEcCtD
Cefpodoxime—Rhinitis—Capecitabine—colon cancer	0.00184	0.00184	CcSEcCtD
Cefpodoxime—Haemorrhage—Capecitabine—colon cancer	0.00184	0.00184	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Fluorouracil—colon cancer	0.00183	0.00183	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Vincristine—colon cancer	0.00182	0.00182	CcSEcCtD
Cefpodoxime—Hypotension—Irinotecan—colon cancer	0.00182	0.00182	CcSEcCtD
Cefpodoxime—Insomnia—Vincristine—colon cancer	0.00181	0.00181	CcSEcCtD
Cefpodoxime—Oedema peripheral—Capecitabine—colon cancer	0.00181	0.00181	CcSEcCtD
Cefpodoxime—Paraesthesia—Vincristine—colon cancer	0.0018	0.0018	CcSEcCtD
Cefpodoxime—Anorexia—Fluorouracil—colon cancer	0.00178	0.00178	CcSEcCtD
Cefpodoxime—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00178	0.00178	CcSEcCtD
Cefpodoxime—Insomnia—Irinotecan—colon cancer	0.00176	0.00176	CcSEcCtD
Cefpodoxime—Paraesthesia—Irinotecan—colon cancer	0.00175	0.00175	CcSEcCtD
Cefpodoxime—Hypotension—Fluorouracil—colon cancer	0.00174	0.00174	CcSEcCtD
Cefpodoxime—Decreased appetite—Vincristine—colon cancer	0.00174	0.00174	CcSEcCtD
Cefpodoxime—Dyspnoea—Irinotecan—colon cancer	0.00174	0.00174	CcSEcCtD
Cefpodoxime—Erythema multiforme—Capecitabine—colon cancer	0.00174	0.00174	CcSEcCtD
Cefpodoxime—Somnolence—Irinotecan—colon cancer	0.00173	0.00173	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Vincristine—colon cancer	0.00173	0.00173	CcSEcCtD
Cefpodoxime—Fatigue—Vincristine—colon cancer	0.00173	0.00173	CcSEcCtD
Cefpodoxime—Dyspepsia—Irinotecan—colon cancer	0.00172	0.00172	CcSEcCtD
Cefpodoxime—Tinnitus—Capecitabine—colon cancer	0.00171	0.00171	CcSEcCtD
Cefpodoxime—Pain—Vincristine—colon cancer	0.00171	0.00171	CcSEcCtD
Cefpodoxime—Constipation—Vincristine—colon cancer	0.00171	0.00171	CcSEcCtD
Cefpodoxime—Asthma—Methotrexate—colon cancer	0.00171	0.00171	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.0017	0.0017	CcSEcCtD
Cefpodoxime—Decreased appetite—Irinotecan—colon cancer	0.00169	0.00169	CcSEcCtD
Cefpodoxime—Eosinophilia—Methotrexate—colon cancer	0.00169	0.00169	CcSEcCtD
Cefpodoxime—Insomnia—Fluorouracil—colon cancer	0.00169	0.00169	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Irinotecan—colon cancer	0.00168	0.00168	CcSEcCtD
Cefpodoxime—Fatigue—Irinotecan—colon cancer	0.00168	0.00168	CcSEcCtD
Cefpodoxime—Paraesthesia—Fluorouracil—colon cancer	0.00168	0.00168	CcSEcCtD
Cefpodoxime—Constipation—Irinotecan—colon cancer	0.00167	0.00167	CcSEcCtD
Cefpodoxime—Pain—Irinotecan—colon cancer	0.00167	0.00167	CcSEcCtD
Cefpodoxime—Dyspnoea—Fluorouracil—colon cancer	0.00166	0.00166	CcSEcCtD
Cefpodoxime—Somnolence—Fluorouracil—colon cancer	0.00166	0.00166	CcSEcCtD
Cefpodoxime—Chills—Capecitabine—colon cancer	0.00165	0.00165	CcSEcCtD
Cefpodoxime—Dyspepsia—Fluorouracil—colon cancer	0.00164	0.00164	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Vincristine—colon cancer	0.00164	0.00164	CcSEcCtD
Cefpodoxime—Decreased appetite—Fluorouracil—colon cancer	0.00162	0.00162	CcSEcCtD
Cefpodoxime—Alopecia—Capecitabine—colon cancer	0.00162	0.00162	CcSEcCtD
Cefpodoxime—Pancytopenia—Methotrexate—colon cancer	0.00162	0.00162	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00161	0.00161	CcSEcCtD
Cefpodoxime—Feeling abnormal—Irinotecan—colon cancer	0.00161	0.00161	CcSEcCtD
Cefpodoxime—Neutropenia—Methotrexate—colon cancer	0.0016	0.0016	CcSEcCtD
Cefpodoxime—Dysuria—Methotrexate—colon cancer	0.0016	0.0016	CcSEcCtD
Cefpodoxime—Pain—Fluorouracil—colon cancer	0.0016	0.0016	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Irinotecan—colon cancer	0.00159	0.00159	CcSEcCtD
Cefpodoxime—Abdominal pain—Vincristine—colon cancer	0.00158	0.00158	CcSEcCtD
Cefpodoxime—Body temperature increased—Vincristine—colon cancer	0.00158	0.00158	CcSEcCtD
Cefpodoxime—Flatulence—Capecitabine—colon cancer	0.00158	0.00158	CcSEcCtD
Cefpodoxime—Dysgeusia—Capecitabine—colon cancer	0.00157	0.00157	CcSEcCtD
Cefpodoxime—Photosensitivity reaction—Methotrexate—colon cancer	0.00156	0.00156	CcSEcCtD
Cefpodoxime—Back pain—Capecitabine—colon cancer	0.00155	0.00155	CcSEcCtD
Cefpodoxime—Abdominal pain—Irinotecan—colon cancer	0.00154	0.00154	CcSEcCtD
Cefpodoxime—Body temperature increased—Irinotecan—colon cancer	0.00154	0.00154	CcSEcCtD
Cefpodoxime—Feeling abnormal—Fluorouracil—colon cancer	0.00154	0.00154	CcSEcCtD
Cefpodoxime—Pneumonia—Methotrexate—colon cancer	0.00153	0.00153	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00151	0.00151	CcSEcCtD
Cefpodoxime—Tremor—Capecitabine—colon cancer	0.0015	0.0015	CcSEcCtD
Cefpodoxime—Renal failure—Methotrexate—colon cancer	0.0015	0.0015	CcSEcCtD
Cefpodoxime—Stomatitis—Methotrexate—colon cancer	0.00148	0.00148	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Capecitabine—colon cancer	0.00148	0.00148	CcSEcCtD
Cefpodoxime—Urticaria—Fluorouracil—colon cancer	0.00148	0.00148	CcSEcCtD
Cefpodoxime—Anaemia—Capecitabine—colon cancer	0.00148	0.00148	CcSEcCtD
Cefpodoxime—Body temperature increased—Fluorouracil—colon cancer	0.00148	0.00148	CcSEcCtD
Cefpodoxime—Hypersensitivity—Vincristine—colon cancer	0.00147	0.00147	CcSEcCtD
Cefpodoxime—Haematuria—Methotrexate—colon cancer	0.00145	0.00145	CcSEcCtD
Cefpodoxime—Malaise—Capecitabine—colon cancer	0.00144	0.00144	CcSEcCtD
Cefpodoxime—Epistaxis—Methotrexate—colon cancer	0.00144	0.00144	CcSEcCtD
Cefpodoxime—Vertigo—Capecitabine—colon cancer	0.00144	0.00144	CcSEcCtD
Cefpodoxime—Hypersensitivity—Irinotecan—colon cancer	0.00144	0.00144	CcSEcCtD
Cefpodoxime—Asthenia—Vincristine—colon cancer	0.00144	0.00144	CcSEcCtD
Cefpodoxime—Syncope—Capecitabine—colon cancer	0.00143	0.00143	CcSEcCtD
Cefpodoxime—Leukopenia—Capecitabine—colon cancer	0.00143	0.00143	CcSEcCtD
Cefpodoxime—Agranulocytosis—Methotrexate—colon cancer	0.00142	0.00142	CcSEcCtD
Cefpodoxime—Palpitations—Capecitabine—colon cancer	0.00141	0.00141	CcSEcCtD
Cefpodoxime—Loss of consciousness—Capecitabine—colon cancer	0.00141	0.00141	CcSEcCtD
Cefpodoxime—Asthenia—Irinotecan—colon cancer	0.0014	0.0014	CcSEcCtD
Cefpodoxime—Cough—Capecitabine—colon cancer	0.00139	0.00139	CcSEcCtD
Cefpodoxime—Hypertension—Capecitabine—colon cancer	0.00138	0.00138	CcSEcCtD
Cefpodoxime—Hypersensitivity—Fluorouracil—colon cancer	0.00138	0.00138	CcSEcCtD
Cefpodoxime—Haemoglobin—Methotrexate—colon cancer	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Diarrhoea—Vincristine—colon cancer	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Haemorrhage—Methotrexate—colon cancer	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Chest pain—Capecitabine—colon cancer	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Myalgia—Capecitabine—colon cancer	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Anxiety—Capecitabine—colon cancer	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Discomfort—Capecitabine—colon cancer	0.00134	0.00134	CcSEcCtD
Cefpodoxime—Diarrhoea—Irinotecan—colon cancer	0.00133	0.00133	CcSEcCtD
Cefpodoxime—Dry mouth—Capecitabine—colon cancer	0.00133	0.00133	CcSEcCtD
Cefpodoxime—Dizziness—Vincristine—colon cancer	0.00132	0.00132	CcSEcCtD
Cefpodoxime—Pruritus—Fluorouracil—colon cancer	0.00132	0.00132	CcSEcCtD
Cefpodoxime—Confusional state—Capecitabine—colon cancer	0.00132	0.00132	CcSEcCtD
Cefpodoxime—Erythema multiforme—Methotrexate—colon cancer	0.00129	0.00129	CcSEcCtD
Cefpodoxime—Dizziness—Irinotecan—colon cancer	0.00129	0.00129	CcSEcCtD
Cefpodoxime—Shock—Capecitabine—colon cancer	0.00128	0.00128	CcSEcCtD
Cefpodoxime—Diarrhoea—Fluorouracil—colon cancer	0.00128	0.00128	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Capecitabine—colon cancer	0.00128	0.00128	CcSEcCtD
Cefpodoxime—Tinnitus—Methotrexate—colon cancer	0.00127	0.00127	CcSEcCtD
Cefpodoxime—Vomiting—Vincristine—colon cancer	0.00127	0.00127	CcSEcCtD
Cefpodoxime—Rash—Vincristine—colon cancer	0.00126	0.00126	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Capecitabine—colon cancer	0.00126	0.00126	CcSEcCtD
Cefpodoxime—Dermatitis—Vincristine—colon cancer	0.00126	0.00126	CcSEcCtD
Cefpodoxime—Headache—Vincristine—colon cancer	0.00125	0.00125	CcSEcCtD
Cefpodoxime—Anorexia—Capecitabine—colon cancer	0.00124	0.00124	CcSEcCtD
Cefpodoxime—Vomiting—Irinotecan—colon cancer	0.00124	0.00124	CcSEcCtD
Cefpodoxime—Dizziness—Fluorouracil—colon cancer	0.00123	0.00123	CcSEcCtD
Cefpodoxime—Rash—Irinotecan—colon cancer	0.00123	0.00123	CcSEcCtD
Cefpodoxime—Dermatitis—Irinotecan—colon cancer	0.00123	0.00123	CcSEcCtD
Cefpodoxime—Chills—Methotrexate—colon cancer	0.00123	0.00123	CcSEcCtD
Cefpodoxime—Headache—Irinotecan—colon cancer	0.00122	0.00122	CcSEcCtD
Cefpodoxime—Hypotension—Capecitabine—colon cancer	0.00122	0.00122	CcSEcCtD
Cefpodoxime—Alopecia—Methotrexate—colon cancer	0.00121	0.00121	CcSEcCtD
Cefpodoxime—Nausea—Vincristine—colon cancer	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Vomiting—Fluorouracil—colon cancer	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Insomnia—Capecitabine—colon cancer	0.00118	0.00118	CcSEcCtD
Cefpodoxime—Rash—Fluorouracil—colon cancer	0.00118	0.00118	CcSEcCtD
Cefpodoxime—Dermatitis—Fluorouracil—colon cancer	0.00118	0.00118	CcSEcCtD
Cefpodoxime—Paraesthesia—Capecitabine—colon cancer	0.00117	0.00117	CcSEcCtD
Cefpodoxime—Headache—Fluorouracil—colon cancer	0.00117	0.00117	CcSEcCtD
Cefpodoxime—Dysgeusia—Methotrexate—colon cancer	0.00117	0.00117	CcSEcCtD
Cefpodoxime—Dyspnoea—Capecitabine—colon cancer	0.00116	0.00116	CcSEcCtD
Cefpodoxime—Nausea—Irinotecan—colon cancer	0.00116	0.00116	CcSEcCtD
Cefpodoxime—Back pain—Methotrexate—colon cancer	0.00115	0.00115	CcSEcCtD
Cefpodoxime—Dyspepsia—Capecitabine—colon cancer	0.00115	0.00115	CcSEcCtD
Cefpodoxime—Decreased appetite—Capecitabine—colon cancer	0.00113	0.00113	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Capecitabine—colon cancer	0.00113	0.00113	CcSEcCtD
Cefpodoxime—Fatigue—Capecitabine—colon cancer	0.00112	0.00112	CcSEcCtD
Cefpodoxime—Constipation—Capecitabine—colon cancer	0.00112	0.00112	CcSEcCtD
Cefpodoxime—Pain—Capecitabine—colon cancer	0.00112	0.00112	CcSEcCtD
Cefpodoxime—Nausea—Fluorouracil—colon cancer	0.00111	0.00111	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Methotrexate—colon cancer	0.0011	0.0011	CcSEcCtD
Cefpodoxime—Anaemia—Methotrexate—colon cancer	0.0011	0.0011	CcSEcCtD
Cefpodoxime—Feeling abnormal—Capecitabine—colon cancer	0.00108	0.00108	CcSEcCtD
Cefpodoxime—Malaise—Methotrexate—colon cancer	0.00107	0.00107	CcSEcCtD
Cefpodoxime—Vertigo—Methotrexate—colon cancer	0.00107	0.00107	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Capecitabine—colon cancer	0.00107	0.00107	CcSEcCtD
Cefpodoxime—Leukopenia—Methotrexate—colon cancer	0.00107	0.00107	CcSEcCtD
Cefpodoxime—Cough—Methotrexate—colon cancer	0.00104	0.00104	CcSEcCtD
Cefpodoxime—Urticaria—Capecitabine—colon cancer	0.00104	0.00104	CcSEcCtD
Cefpodoxime—Abdominal pain—Capecitabine—colon cancer	0.00103	0.00103	CcSEcCtD
Cefpodoxime—Body temperature increased—Capecitabine—colon cancer	0.00103	0.00103	CcSEcCtD
Cefpodoxime—Convulsion—Methotrexate—colon cancer	0.00103	0.00103	CcSEcCtD
Cefpodoxime—Chest pain—Methotrexate—colon cancer	0.00101	0.00101	CcSEcCtD
Cefpodoxime—Myalgia—Methotrexate—colon cancer	0.00101	0.00101	CcSEcCtD
Cefpodoxime—Discomfort—Methotrexate—colon cancer	0.001	0.001	CcSEcCtD
Cefpodoxime—Confusional state—Methotrexate—colon cancer	0.000979	0.000979	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Methotrexate—colon cancer	0.000971	0.000971	CcSEcCtD
Cefpodoxime—Hypersensitivity—Capecitabine—colon cancer	0.000961	0.000961	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Methotrexate—colon cancer	0.000951	0.000951	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Methotrexate—colon cancer	0.000939	0.000939	CcSEcCtD
Cefpodoxime—Asthenia—Capecitabine—colon cancer	0.000936	0.000936	CcSEcCtD
Cefpodoxime—Anorexia—Methotrexate—colon cancer	0.000926	0.000926	CcSEcCtD
Cefpodoxime—Pruritus—Capecitabine—colon cancer	0.000923	0.000923	CcSEcCtD
Cefpodoxime—Hypotension—Methotrexate—colon cancer	0.000908	0.000908	CcSEcCtD
Cefpodoxime—Diarrhoea—Capecitabine—colon cancer	0.000893	0.000893	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000885	0.000885	CcSEcCtD
Cefpodoxime—Insomnia—Methotrexate—colon cancer	0.000878	0.000878	CcSEcCtD
Cefpodoxime—Paraesthesia—Methotrexate—colon cancer	0.000872	0.000872	CcSEcCtD
Cefpodoxime—Dyspnoea—Methotrexate—colon cancer	0.000866	0.000866	CcSEcCtD
Cefpodoxime—Somnolence—Methotrexate—colon cancer	0.000863	0.000863	CcSEcCtD
Cefpodoxime—Dizziness—Capecitabine—colon cancer	0.000863	0.000863	CcSEcCtD
Cefpodoxime—Dyspepsia—Methotrexate—colon cancer	0.000855	0.000855	CcSEcCtD
Cefpodoxime—Decreased appetite—Methotrexate—colon cancer	0.000844	0.000844	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Methotrexate—colon cancer	0.000838	0.000838	CcSEcCtD
Cefpodoxime—Fatigue—Methotrexate—colon cancer	0.000837	0.000837	CcSEcCtD
Cefpodoxime—Pain—Methotrexate—colon cancer	0.000831	0.000831	CcSEcCtD
Cefpodoxime—Vomiting—Capecitabine—colon cancer	0.00083	0.00083	CcSEcCtD
Cefpodoxime—Rash—Capecitabine—colon cancer	0.000823	0.000823	CcSEcCtD
Cefpodoxime—Dermatitis—Capecitabine—colon cancer	0.000822	0.000822	CcSEcCtD
Cefpodoxime—Headache—Capecitabine—colon cancer	0.000817	0.000817	CcSEcCtD
Cefpodoxime—Feeling abnormal—Methotrexate—colon cancer	0.0008	0.0008	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Methotrexate—colon cancer	0.000794	0.000794	CcSEcCtD
Cefpodoxime—Nausea—Capecitabine—colon cancer	0.000775	0.000775	CcSEcCtD
Cefpodoxime—Urticaria—Methotrexate—colon cancer	0.000772	0.000772	CcSEcCtD
Cefpodoxime—Abdominal pain—Methotrexate—colon cancer	0.000768	0.000768	CcSEcCtD
Cefpodoxime—Body temperature increased—Methotrexate—colon cancer	0.000768	0.000768	CcSEcCtD
Cefpodoxime—Hypersensitivity—Methotrexate—colon cancer	0.000716	0.000716	CcSEcCtD
Cefpodoxime—Asthenia—Methotrexate—colon cancer	0.000697	0.000697	CcSEcCtD
Cefpodoxime—Pruritus—Methotrexate—colon cancer	0.000687	0.000687	CcSEcCtD
Cefpodoxime—Diarrhoea—Methotrexate—colon cancer	0.000665	0.000665	CcSEcCtD
Cefpodoxime—Dizziness—Methotrexate—colon cancer	0.000642	0.000642	CcSEcCtD
Cefpodoxime—Vomiting—Methotrexate—colon cancer	0.000618	0.000618	CcSEcCtD
Cefpodoxime—Rash—Methotrexate—colon cancer	0.000612	0.000612	CcSEcCtD
Cefpodoxime—Dermatitis—Methotrexate—colon cancer	0.000612	0.000612	CcSEcCtD
Cefpodoxime—Headache—Methotrexate—colon cancer	0.000608	0.000608	CcSEcCtD
Cefpodoxime—Nausea—Methotrexate—colon cancer	0.000577	0.000577	CcSEcCtD
